These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

189 related items for PubMed ID: 33616089

  • 1. Chemical Conjugation of a Purified DEC-205-Directed Antibody with Full-Length Protein for Targeting Mouse Dendritic Cells In Vitro and In Vivo.
    Volckmar J, Knop L, Hirsch T, Frentzel S, Erck C, van Ham M, Stegemann-Koniszewski S, Bruder D.
    J Vis Exp; 2021 Feb 05; (168):. PubMed ID: 33616089
    [Abstract] [Full Text] [Related]

  • 2. The STING activator c-di-AMP exerts superior adjuvant properties than the formulation poly(I:C)/CpG after subcutaneous vaccination with soluble protein antigen or DEC-205-mediated antigen targeting to dendritic cells.
    Volckmar J, Knop L, Stegemann-Koniszewski S, Schulze K, Ebensen T, Guzmán CA, Bruder D.
    Vaccine; 2019 Aug 14; 37(35):4963-4974. PubMed ID: 31320219
    [Abstract] [Full Text] [Related]

  • 3. Efficient targeting of protein antigen to the dendritic cell receptor DEC-205 in the steady state leads to antigen presentation on major histocompatibility complex class I products and peripheral CD8+ T cell tolerance.
    Bonifaz L, Bonnyay D, Mahnke K, Rivera M, Nussenzweig MC, Steinman RM.
    J Exp Med; 2002 Dec 16; 196(12):1627-38. PubMed ID: 12486105
    [Abstract] [Full Text] [Related]

  • 4. Antibody-antigen-adjuvant conjugates enable co-delivery of antigen and adjuvant to dendritic cells in cis but only have partial targeting specificity.
    Kreutz M, Giquel B, Hu Q, Abuknesha R, Uematsu S, Akira S, Nestle FO, Diebold SS.
    PLoS One; 2012 Dec 16; 7(7):e40208. PubMed ID: 22808118
    [Abstract] [Full Text] [Related]

  • 5. In vivo targeting of antigens to maturing dendritic cells via the DEC-205 receptor improves T cell vaccination.
    Bonifaz LC, Bonnyay DP, Charalambous A, Darguste DI, Fujii S, Soares H, Brimnes MK, Moltedo B, Moran TM, Steinman RM.
    J Exp Med; 2004 Mar 15; 199(6):815-24. PubMed ID: 15024047
    [Abstract] [Full Text] [Related]

  • 6. Enhancement of the priming efficacy of DNA vaccines encoding dendritic cell-targeted antigens by synergistic toll-like receptor ligands.
    Grossmann C, Tenbusch M, Nchinda G, Temchura V, Nabi G, Stone GW, Kornbluth RS, Uberla K.
    BMC Immunol; 2009 Aug 03; 10():43. PubMed ID: 19650904
    [Abstract] [Full Text] [Related]

  • 7. Exploring the vaccine potential of Dec-205 targeting in Mycobacterium tuberculosis infection in mice.
    Stylianou E, Pepponi I, van Dolleweerd CJ, Paul MJ, Ma JK, Reljic R.
    Vaccine; 2011 Mar 09; 29(12):2279-86. PubMed ID: 21272603
    [Abstract] [Full Text] [Related]

  • 8. Targeting of rotavirus VP6 to DEC-205 induces protection against the infection in mice.
    Badillo-Godinez O, Gutierrez-Xicotencatl L, Plett-Torres T, Pedroza-Saavedra A, Gonzalez-Jaimes A, Chihu-Amparan L, Maldonado-Gama M, Espino-Solis G, Bonifaz LC, Esquivel-Guadarrama F.
    Vaccine; 2015 Aug 20; 33(35):4228-37. PubMed ID: 25850020
    [Abstract] [Full Text] [Related]

  • 9. Targeting the antigen encoded by adenoviral vectors to the DEC205 receptor modulates the cellular and humoral immune response.
    Tenbusch M, Nchinda G, Storcksdieck genannt Bonsmann M, Temchura V, Überla K.
    Int Immunol; 2013 Apr 20; 25(4):247-58. PubMed ID: 23184617
    [Abstract] [Full Text] [Related]

  • 10. Targeting of DEC-205 on human dendritic cells results in efficient MHC class II-restricted antigen presentation.
    Birkholz K, Schwenkert M, Kellner C, Gross S, Fey G, Schuler-Thurner B, Schuler G, Schaft N, Dörrie J.
    Blood; 2010 Sep 30; 116(13):2277-85. PubMed ID: 20566893
    [Abstract] [Full Text] [Related]

  • 11. DEC-205 receptor-mediated long-circling nanoliposome as an antigen and Eucommia ulmoides polysaccharide delivery system enhances the immune response via facilitating dendritic cells maturation.
    Feng H, Yang X, Fan J, Zhang L, Liu Q, Chai D.
    Drug Deliv; 2020 Dec 30; 27(1):1581-1596. PubMed ID: 33169636
    [Abstract] [Full Text] [Related]

  • 12. Targeting dendritic cells in humanized mice receiving adoptive T cells via monoclonal antibodies fused to Flu epitopes.
    Graham JP, Authie P, Yu CI, Zurawski SM, Li XH, Marches F, Flamar AL, Acharya A, Banchereau J, Palucka AK.
    Vaccine; 2016 Sep 22; 34(41):4857-4865. PubMed ID: 27595442
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Induction of innate and adaptive immunity by delivery of poly dA:dT to dendritic cells.
    Barbuto S, Idoyaga J, Vila-Perelló M, Longhi MP, Breton G, Steinman RM, Muir TW.
    Nat Chem Biol; 2013 Apr 22; 9(4):250-6. PubMed ID: 23416331
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Broad T cell immunity to the LcrV virulence protein is induced by targeted delivery to DEC-205/CD205-positive mouse dendritic cells.
    Do Y, Park CG, Kang YS, Park SH, Lynch RM, Lee H, Powell BS, Steinman RM.
    Eur J Immunol; 2008 Jan 22; 38(1):20-9. PubMed ID: 18081041
    [Abstract] [Full Text] [Related]

  • 18. HIV gag protein is efficiently cross-presented when targeted with an antibody towards the DEC-205 receptor in Flt3 ligand-mobilized murine DC.
    Bozzacco L, Trumpfheller C, Huang Y, Longhi MP, Shimeliovich I, Schauer JD, Park CG, Steinman RM.
    Eur J Immunol; 2010 Jan 22; 40(1):36-46. PubMed ID: 19830741
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.